使用智能手机和基于Web的应用程序与老年人进行认知训练:一个范围广泛的审查
A F Silva1, R M Silva, E Murawska-Ciałowicz
1Rui Miguel Silva, Escola Superior de Desporto e Lazer - Instituto Politécnico de Viana do Castelo, Complexo Desportivo e Lazer Comendador Rui Solheiro Monte de Prado, 4960-320 Melgaço, Tel.. +351 258 809 678, rui.s@ipvc.pt.
The journal of prevention of Alzheimer's disease
|May 6, 2024
概括
这次范围审查发现了各种各样的认知训练应用程序协议. 未来的研究应该解决方法论的局限性,并考虑个体差异,探索现实世界的有效性.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 数字健康数字健康
背景情况:
- 范围审查审查数字认知训练干预措施.
- 确定了常见的应用程序,训练频率和有针对性的认知功能.
- 突出了现有的研究方法的局限性和差异.
研究的目的:
- 系统地审查和综合有关认知训练应用的现有研究.
- 识别应用使用趋势,干预频率和目标认知领域.
- 强调在数字认知干预中需要改进研究方法的需要.
主要方法:
- 遵守PRISMA (系统审查和元分析的首选报告项目) 准则.
- 在主要数据库中进行全面的文献搜索:科学网,PsycInfo,Cochrane和PubMed.
- 从最初的1733篇识别文章中包括34篇研究.
主要成果:
- 在研究中的干预方案中观察到显著的异质性.
- 确定了未来研究的需要,以解决方法限制和不一致的问题.
- 该审查综合了应用程序使用,训练频率和目标认知功能的数据.
结论:
- 认知训练干预方案表现出相当大的多样性.
- 将身体健康评估与认知评估相结合,可以全面了解综合干预影响.
- 进一步调查认知训练应用的有效性至关重要,考虑到个体的变化和现实世界的适用性.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
13.7K
相关概念视频
Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
